Natera Oncology

New Data Review: Can treating molecular residual disease (MRD) in colorectal cancer (CRC) improve outcomes?🧬 Join us for a webinar and discussion surrounding the management of CRC using MRD testing and the role of ctDNA in enabling new drug development opportunities in early-stage disease. We will dive into the latest data from publications and ASCO GI, which sheds light on the impact of treatment on MRD. Register today. https://ow.ly/ZkbL50VrHUe

We are honored to witness the annual #UnitedinBlue flag installation from Fight Colorectal Cancer 🏛️💙 Their mission to empower colorectal cancer patients and drive change inspires us each year. Fight CRC works tirelessly to: ✔ Advocate for policy changes that expand CRC patient access to care. ✔ Connect survivors with resources to navigate their diagnosis. ✔ Fund research and awareness efforts to improve patient outcomes. 📣 Natera believes in the power of advocacy, and we support Fight CRC’s work! Learn more at https://ow.ly/Renh50Vg3FT #FightCRC #ColorectalCancer

This past weekend, Team Natera supported the Scope It Out event with our partners at the Colorectal Cancer Alliance. Hearing survivors’ stories firsthand reminded us why we innovate in MRD testing—to help make a difference in patient care. Pictured is Team Natera (Kelly Mellott, Justin Yackle, George Laliotis, Rick Sause, Lauren Kangerloo, Shanika Kennedy, and Alan McKenna). #Natera #CRC #SurvivorStrong #ScopeItOut

Lynch syndrome is an inherited condition that increases risk of colon cancer, endometrial cancer, ovarian cancer, and several other cancers. Lynch syndrome is the most common inherited cause of colon cancer and endometrial cancer. This Lynch Syndrome Awareness Day, learn more and help patients and their families get ahead of cancer by accessing high-quality, affordable genetic testing. https://ow.ly/MsqS50VmyHG #GeneticTesting #LynchSyndrome #CRCAwareness #CancerAwareness

When Jason Randall was diagnosed with stage IV colorectal cancer, he had a choice—let cancer control his future or take control of his care. Signatera MRD testing helped give him the information he needed to take control. Through multiple recurrences, Jason used MRD testing to monitor his disease, make treatment decisions, and stay ahead of cancer. Today, he’s fulfilling his dream of building a cancer retreat in Hawaii. His story is one of hope, strength, and perseverance. https://ow.ly/VB8l50VkeA6 #ColorectalCancerAwareness #Signatera #Natera

🔵 We’re proud to support Colorectal Cancer Alliance in their mission to provide education, support, and advocacy for colorectal cancer patients. Through initiatives like Walk to End Colon Cancer, AllyCon, and patient resources like BlueHQ, CCA ensures no one faces CRC alone. 💙 Why their work matters: ✔ Helping patients navigate their diagnosis with confidence. ✔ Funding critical research & early detection efforts. ✔ Building a strong, supportive community for CRC survivors. 📣 Looking for support? Visit Colorectal Cancer Alliance: https://ow.ly/ALEf50VgyH5 #ColorectalCancerAwareness #PatientAdvocacy #CCAlliance

💙 March is Colorectal Cancer (CRC) Awareness Month—a time to show support for patients, survivors, and families impacted by this disease. Through innovative molecular residual disease (MRD) testing and partnerships with advocacy organizations, we are committed to supporting people with CRC. No one should navigate this alone. If you or a loved one has been affected by CRC, we’re here to help. Drop a 💙 in the comments to show your support for the CRC community. #ColorectalCancerAwareness #MRDTesting #DressinBlue

Great discussions at the CCGCoP Cancer Genomics Bootcamp in Pasadena! Our session, Expanding patient access to germline testing through Natera’s Oncology Hereditary Cancer Alert Program, was presented by Naterans Kevin Manage, PhD, and Kati Young, MS, CGC. #GermlineTesting #Natera

Medicare now covers Signatera for lung cancer patients. Early detection = early treatment, with potential to deliver huge cost savings and improve outcomes for patients. Well done Medicare! Another win for cancer care in good ol' USA

March is National #ColorectalCancerAwarenessMonth. Colorectal cancer is the leading cause of cancer death in men, and second for women. Show your support and spread the word by: 👉 Sharing on social media 👉 Buying merch & advocating wherever you go 👉 Wearing blue March 7 for #DressInBlueDay 👉 Creating a Facebook fundraiser for the Alliance Get more info at https://lnkd.in/gwwsCYPy Thank you to Olympus Corporation of the Americas and Merck for supporting National Colorectal Cancer Awareness Month.